Related Experiment Videos
Parkinson's disease with recurrent pulmonary embolism
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed
|August 5, 2000
Summary
Pulmonary embolism is a serious risk for Parkinson's patients, often presenting as chest pain or dyspnea. Early diagnosis and anticoagulation therapy can effectively manage this condition.
Area of Science:
- Neurology
- Cardiology
- Pulmonology
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder.
- Pulmonary embolism (PE) is a significant cause of morbidity and mortality.
- Levodopa is a common treatment for Parkinson's disease.
Observation:
- A patient with Parkinson's disease presented with recurrent chest pain and dyspnea.
- Clinical suspicion and lung scan confirmed pulmonary embolism.
- The patient received anticoagulation therapy.
Findings:
- Pulmonary embolism is a potential adverse effect of levodopa therapy.
- PE is an under-recognized cause of death in parkinsonism patients.
- Anticoagulation therapy led to symptom resolution and a two-year symptom-free follow-up.
Implications:
- Clinicians should consider PE in parkinsonian patients with chest pain and dyspnea.
- Prompt diagnosis and management of PE are crucial in this population.
- This case highlights the importance of recognizing PE as a complication of Parkinson's disease treatment.